JD

Jakob Dupont

Imugene Limited | Non-Executive Director
Dr Dupont is an industry and drug development expert with more than 20 years of experience specialising in oncology and other therapeutic areas. Dr Dupont is currently the Executive Venture Partner at Sofinnova Investments. Dr Dupont's experience includes NASDAQ listed Atara Biotherapeutics (NASDAQ: ATRA), where he oversaw all research and development, including three clinical stage programs spanning Phase 1 through to Phase 3, and numerous preclinical programs. He is a Member of the Risk Committee.

Company and Role

Company
Title
Tenure
Since
IMU
IMU
Imugene Limited
  • Non-Executive Director
3yrs, 10mthSep 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
IMU
Imugene Limited
01/07/2639,391N/A64,392N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMU
IMU
Imugene Limited
01/07/26
Issued
7,353$0.140$1,029Conversion of securities
IMU
IMU
Imugene Limited
01/07/26
Exercise
7,353$0.140$1,029Conversion of securities
IMU
IMU
Imugene Limited
30/06/26
Expiry
11,764$0.115$1,352Options expired
IMU
IMU
Imugene Limited
17/12/25
Issued
14,706$0.320$4,705Conversion of securities
IMU
IMU
Imugene Limited
17/12/25
Exercise
14,706$0.320$4,705Conversion of securities